HE homepage

Trending
Foreign national accused of operating fake company that billed Medicare for $90M—and now he’s on the run
Healthcare educators: Want to stabilize nurse staffing for years to come? Stand up for the Nurse Faculty Loan Program
FTC homes in on healthcare
AI-powered CCTA assessments show ‘close agreement’ with IVUS
Former ACA Marketplace enrollee: ‘This is ridiculous—$1,200 and an $8,000 deductible for a healthy person. Really?’
patient experience
More than 80% of clinicians have had to correct AI-supplied misinformation during patient visits: New patient + provider survey

Meanwhile members of Gen Z are twice as likely as other generations to get sneaky about their use of medical AI. 

Fax
CMS leaves the ’80s behind with shift away from snail mail correspondence, fax machines

In a Final Rule revealed last week, the Centers for Medicare & Medicaid Services outlined its plan to exchange medical records, diagnostic images and clinical notes electronically using secure protocols. Once the rule is published in the Federal Register, any HIPAA-covered entity that interacts with Medicare will have two years to follow CMS into the modern age.

U.S. FDA Sign
Drugmaker’s stock tumbles 20% after FDA issues formal warning to executives

ImmunityBio, the developer of bladder cancer treatment Anktiva, is accused by the U.S. Food and Drug Administration of disseminating “false or misleading information” about the drug's efficacy in an advertisement and podcast. The FDA said it’s not the first time it's sent a warning letter to the company’s executives over allegedly inaccurate claims.

FTC Apex Building
FTC homes in on healthcare

The federal regulatory agency that exists to protect consumers and promote competition across the economy is newly focused on patients and clinicians as well as taxpayers.  

Example of an automated artificial intelligence (AI) assessment of soft coronary plaque from a CT scan from the vendor Cleerly. This image shows the AI's reconstruction of a patient's coronary tree and color codes the vessel segments by the amount of overall plaque burden. The AI gives a very detailed report of all the plaque in all the coronary vessels. Some cardiology experts believe this may be the way of the future in screening patients for early coronary disease and monitoring the impact of prevention
AI-powered CCTA assessments show ‘close agreement’ with IVUS

Advanced AI software developed by Cleerly consistently produced plaque assessments comparable to intravascular ultrasound. 

angry executive businessman
Former ACA Marketplace enrollee: ‘This is ridiculous—$1,200 and an $8,000 deductible for a healthy person. Really?’

A new KFF survey shows almost 10% of people who had an Obamacare Marketplace plan in 2025 decided to head into 2026 with no coverage at all. Another 28% re-enrolled but with a different—presumably lesser—plan. 

UnitedHealthcare CEO Brian Thompson
New York man pleads guilty to cyberstalking family of murdered UnitedHealthcare CEO

Authorities said Shane Daley, 40, began making threatening calls mere hours after Brian Thompson was shot and killed outside a hotel in Manhattan. Daley awaits sentencing and faces up to five years in prison.

money puzzle innovation funding
Healthcare price transparency startup earns $40M in seed funding, bringing the total to $95M

San Diego-based Turquoise Health was founded in 2020 and has evolved to be a healthcare pricing engine used to develop health plan networks and contract rates. The company said its end goal is complete price transparency to make it easier for all organizations and patients to navigate the U.S. healthcare system.

Congress Senate Washington D.C. DC
EP advocacy group details 6 key policy issues

The Heart Rhythm Society's advocacy arm is monitoring such issues as prior authorization, outpatient payment policies and cancelled research funding. 

Around the web

Radiology Business
Imaging manufacturer Guerbet faces financial challenges following recent FDA warning

Regulators recently scolded the France-based pharmaceutical firm for safety issues that occurred at its plant in Raleigh, North Carolina, which produces imaging contrast agents.